cell head and neck cancer with robotic selective neck dissection - TopicsExpress



          

cell head and neck cancer with robotic selective neck dissection (Otolaryngology Head and Neck Surgery 2013, doi:0194599813515431). Studies of this kind can be hard to generalise from, but it seems that robot assisted selective neck dissection by a postauricular facelift approach can achieve good tumour clearance with improved cosmetic results. Ondansetron is a good example of the absurdities of NHS drug pricing. In 2012, the basic cost of a pack of 30 generic 4 mg tablets was £63.06 (€75.67; $103.09); now it is £16.85. This big drop may be timely if the drug fulfils the promise of a recent randomised crossover trial in irritable bowel syndrome with diarrhoea (Gut 2013, doi:10.1136/ gutjnl-2013-305989). The trial recruited 120 patients and lasted just five weeks, during which “65% reported adequate relief with ondansetron but not placebo compared with 14% reporting relief with placebo but not ondansetron, relative risk 4.7, 95% CI 2.6 to 8.5, P
Posted on: Mon, 23 Jun 2014 16:28:35 +0000

Trending Topics



Recently Viewed Topics




© 2015